Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Chiesi Group Completes Acquisition of KalVista Pharmaceuticals

Friday, June 12, 2026

Chiesi Group a researchfocused biopharmaceutical company has completed its acquisition of KalVista Pharmaceuticals KalVista will now operate as part of Chiesis Rare Diseases business unit

Rewrite this news in-house style based on British English without Plagiarism, remove direct speeches, and Use simple and uncomplicated language as far as possible.

Thursday, June 11, 2026

Orionis Biosciences has entered into an expanded multiyear collaboration with Novartis to discover and develop molecular glue medicines targeting difficulttotreat diseases across multiple therapeutic areas

PharmaEssentia Secures Taiwan Approval of BESREMi for Essential Thrombocythaemia

Thursday, June 11, 2026

PharmaEssentia has received approval from Taiwans Ministry of Health and Welfare MOHW for BESREMi ropeginterferon alfabnjft to treat adult patients with essential thrombocythaemia ET

Antengene Receives China IND Approval for ATG-201 Autoimmune Disease Study

Wednesday, June 10, 2026

Antengene has received Investigational New Drug IND approval from Chinas National Medical Products Administration NMPA to begin the Phase I ATTRACT study of ATG a CD CD bispecific

Nxera Joins OpenFold AI Research Consortium to Strengthen Drug Discovery Capabilities

Wednesday, June 10, 2026

Nxera Pharma has joined OpenFold a nonprofit artificial intelligence research consortium focused on developing opensource AI tools for biology and drug discovery

Everest Medicines Enters into Agreement with Vcare PharmaTech for Sumecigrel

Tuesday, June 09, 2026

Everest Medicines has entered into an exclusive licensing agreement with Vcare PharmaTech for the development registration and commercialisation of Sumecigrel across the AsiaPacific region

Engitix and GSK Partner to Identify New Targets for Liver Fibrosis Regression

Tuesday, June 09, 2026

Engitix has entered into a strategic research collaboration and option agreement with GSK to identify and validate novel therapeutic targets aimed at promoting liver fibrosis regression

Everest Medicines Enters into Agreement with Corxel Pharmaceuticals to Develop and Commercialise LNZ100

Monday, June 08, 2026

Everest Medicines has entered into an asset purchase agreement with Corxel Pharmaceuticals to acquire the rights to develop manufacture and commercialise LNZ in Greater China including mainland China Hong Kong SAR Macao SAR and Taiwan

Roche and Nurix Therapeutics Partner to Advance BTK Degrader Bexobrutideg

Monday, June 08, 2026

Roche has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics to codevelop and cocommercialise bexobrutideg NX an investigational Brutons Tyrosine Kinase BTK degrader

Stipple Bio Signs Licensing Agreement with Lonza for Precision Oncology ADC Development

Friday, June 05, 2026

Stipple Bio has entered a multitarget licensing agreement with Lonza to support the development of nextgeneration antibodydrug conjugate ADC therapies for cancer treatment